19 results
8-K
EX-99.3
SLDB
Solid Biosciences Inc
5 Dec 22
Solid Biosciences Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement
7:48am
as the Company continues its research and development (R&D) programs and develops its product candidates.
The Company expects that its cash on hand
8-K
EX-99.2
SLDB
Solid Biosciences Inc
5 Dec 22
Solid Biosciences Announces Closing of Acquisition of AavantiBio and Concurrent $75 Million Private Placement
7:48am
continues its research and development (R&D) programs and develop its product candidates.
The Company expects that its cash on hand of $39.9 million … , net of federal benefit
Permanent differences
R&D credits
Change in deferred tax rate
Convertible debt
Other
Valuation allowance
Net deferred tax assets
DEFA14A
es5t3rxr
30 Sep 22
Additional proxy soliciting materials
4:08pm
8-K
EX-99.1
39uj6rn5
30 Sep 22
Business Update Call
4:07pm
8-K
EX-99.2
tib1lp3dt kzs1
30 Sep 22
Solid Biosciences Announces Acquisition of AavantiBio and Concurrent $75 Million Private Placement
7:09am
PRE 14A
6ulint66z8exb2 zd
15 Apr 22
Preliminary proxy
4:18pm
8-K
EX-99.1
z057b5
16 Aug 21
Solid Biosciences Provides Second Quarter 2021 Business Update and Financial Results
12:00am
8-K
EX-99.1
zj135jry
14 May 21
Solid Biosciences Provides First Quarter 2021 Business Update and Financial Results
7:55am
8-K
j571mkplgwt8osvpl
5 Mar 21
Departure of Directors or Certain Officers
8:06am
- Prev
- 1
- Next